MedTrace Logo

Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma

NCT06301048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2024-03-08

No results posted yet for this study

Summary

This is a retrospective study, including 79 patients with duodenal papillary adenoma, who treated with Endoscopic Papillectomy (EP) at Beijing friendship hospital. The cohort included patients who underwent EP with or without Pancreatic Duct (PD) and Common Bile Duct (CBD) stent placement. The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates.

Conditions

  • Duodenal Adenoma
  • Complication of Treatment

Interventions

PROCEDURE

Stent Placement in Pancreatic and Bile Ducts

Post-resection, endoscopic retrograde cholangiopancreatography (ERCP) was performed for stent placement in pancreatic or bile ducts as needed, with X-ray confirmation of stent positioning.

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Fujing Lv, M.D. · Beijing Friendship Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-07
Primary Completion
2023-12-07
Completion
2023-12-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06301048 on ClinicalTrials.gov